New blood marker can detect chronic kidney disease, study showsBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5894 (Published 09 November 2015) Cite this as: BMJ 2015;351:h5894
- Susan Mayor
Measuring blood concentrations of soluble urokinase-type plasminogen activating receptor (suPAR), the circulating form of a membrane transport protein, can reliably predict a person’s risk of developing chronic kidney disease up to five years before the condition starts to cause tissue damage, shows a study that may improve early detection, prevention, and monitoring.1
The study, published in the New England Journal of Medicine, measured suPAR concentrations in 3683 people enrolled in the Emory Cardiovascular Biobank, a prospective registry of patients undergoing cardiac catheterization at three hospitals in Atlanta, Georgia, between 2003 and 2009. Researchers assessed participants’ renal function at the start of the study and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial